ELIZABETH LARSEN: Open Payments
NPI 1093770562 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 37 payments from 14 companies in 2025. Trend: 2023 $787 · 2024 $597 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $354 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Organon LLC | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Corium, LLC | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: QULIPTA, VRAYLAR, UBRELVY, Qelbree, NEXPLANON, XIFAXAN, JOURNAVX, Azstarys.
Industry payments across UT — which companies pay providers there.
